Journal of Oncology

Pathogenesis and New Therapeutic Targets of Ovarian Cancer


Publishing date
15 Mar 2012
Status
Published
Submission deadline
15 Sep 2011

Lead Editor

1Departments of Pathology, Oncology and Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA

2Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Cathay General Hospital, Taipei, Taiwan

3Department of Gynecology and Obstetrics, Shimane University, Izumo, Japan

4Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH, USA


Pathogenesis and New Therapeutic Targets of Ovarian Cancer

Description

Ovarian cancer is one of the most aggressive neoplastic diseases in women. It is composed of different types of carcinoma with distinct clinicopathological and molecular features. There are several research areas that need to be urgently addressed in order to gain more insight into this devastating disease and provide promise in developing new therapeutic regimens to improve the clinical outcome in ovarian cancer patients. This special issue provides a timely opportunity to publish those studies that aim at exploring the molecular and translational aspects of ovarian cancer. Both original research articles and succinct review papers are all welcome. It is expected that this new special issue on ovarian cancer will become a useful resource for all investigators and clinicians who are interested in ovarian cancer research and will inspire new research directions in the years to come. Potential topics include, but are not limited to:

  • Molecular pathogenesis and molecular signature of different types of ovarian carcinoma
  • Potential molecular targets for anticancer regimens, especially those targeting multiple cancer-related pathways
  • New biomarkers for detection and prognostic prediction
  • Analysis of The Cancer Genome Atlas in ovarian cancer

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/jo/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2012
  • - Article ID 867512
  • - Editorial

Pathogenesis and New Therapeutic Targets of Ovarian Cancer

Ie-Ming Shih | Chih-Ming Ho | ... | Ritu Salani
  • Special Issue
  • - Volume 2012
  • - Article ID 302858
  • - Review Article

Early Detection of Ovarian Cancer with Conventional and Contrast-Enhanced Transvaginal Sonography: Recent Advances and Potential Improvements

Arthur C. Fleischer | Andrej Lyshchik | ... | David A. Fishman
  • Special Issue
  • - Volume 2012
  • - Article ID 468615
  • - Review Article

GRP78 Protein Expression in Ovarian Cancer Patients and Perspectives for a Drug-Targeting Approach

Florence Delie | Patrick Petignat | Marie Cohen
  • Special Issue
  • - Volume 2012
  • - Article ID 382159
  • - Review Article

Special Agents Hunting Down Women Silent Killer: The Emerging Role of the p38α Kinase

Valentina Grossi | Cristiano Simone
  • Special Issue
  • - Volume 2012
  • - Article ID 345164
  • - Review Article

Regulatory T Cells in Human Ovarian Cancer

Dong-Jun Peng | Rebecca Liu | Weiping Zou
  • Special Issue
  • - Volume 2012
  • - Article ID 737981
  • - Review Article

Optimizing Molecular-Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways

Donavon Hiss
  • Special Issue
  • - Volume 2012
  • - Article ID 915140
  • - Review Article

Integrin Inhibitors as a Therapeutic Agent for Ovarian Cancer

Kenjiro Sawada | Chifumi Ohyagi-Hara | ... | Ken-ichirou Morishige
  • Special Issue
  • - Volume 2012
  • - Article ID 682480
  • - Review Article

Ovarian Cancer: Opportunity for Targeted Therapy

Tomoko Tagawa | Robert Morgan | ... | Joanne Mortimer
  • Special Issue
  • - Volume 2012
  • - Article ID 621685
  • - Research Article

DNA Damage Response is Prominent in Ovarian High-Grade Serous Carcinomas, Especially Those with Rsf-1 (HBXAP) Overexpression

Malti Kshirsagar | Wei Jiang | Ie-Ming Shih
Journal of Oncology
 Journal metrics
Acceptance rate33%
Submission to final decision93 days
Acceptance to publication48 days
CiteScore3.220
Impact Factor2.600
 Submit